Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Int J Impot Res ; 26(2): 45-50, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-23903908

RESUMEN

This study evaluated the action of pomegranate juice (PJ) and its five principal phenolic constituents on rat corpus cavernosum smooth muscle (CCSM). Isometric tension studies were performed after precontraction with phenylephrine in CCSM from rats. Relaxant responses to PJ and its constituents ellagic acid (EA), chlorogenic acid, caffeic acid, cumaric acid and rutin were investigated. PJ and EA caused CCSM relaxations (94.1 ± 3.7 and 51.3 ± 9.9%), while others induced limited relaxant responses. EA response was not inhibited by L-N(G)-nitroarginine methyl ester (100 µM) and 1H-[1,2,4]-oxadiazolo[4,3-a]quinoxalin-1-one (1 µM). Tetraethylammonium (100 µM) and apamin (10 µM) and nifedipine (10 µM) inhibited EA-induced relaxations at 10(-3) M by 84%, 82% and 78%, respectively. Glibenclamide (10 µM) inhibited EA response (97%, 100 µM). PJ-induced relaxation was not altered by several inhibitors. EA was estimated to be responsible for 13.3% of relaxation caused by PJ. Our study demonstrated that PJ and EA-induced marked relaxations in CCSM. The opening of Ca(2+)-activated K+ channels and the inhibition of Ca(2+)-channels regulate the relaxation by EA, but not PJ. EA has a minor contribution to the marked relaxation obtained by PJ, suggesting the presence of other PJ constituents, which induce nitric oxide-independent corporal relaxation. Further studies are needed to examine the potential of PJ in combination with a PDE5 inhibitor in ED.


Asunto(s)
Lythraceae , Relajación Muscular/efectos de los fármacos , Músculo Liso/efectos de los fármacos , Pene/efectos de los fármacos , Extractos Vegetales/farmacología , Animales , Apamina , Colforsina , Ácido Elágico/análisis , Ácido Elágico/farmacología , Gliburida , Técnicas In Vitro , Masculino , NG-Nitroarginina Metil Éster , Nifedipino , Oxadiazoles , Piperazinas , Extractos Vegetales/química , Purinas , Quinoxalinas , Ratas , Citrato de Sildenafil , Sulfonas , Tetraetilamonio
2.
Case Rep Med ; 2013: 539761, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23424594

RESUMEN

Loss of vision is a rare complication seen in hemodialysis patients. It is thought to develop because of the hypotension that can be observed during dialysis. This paper involves a patient with acute loss of vision during hemodialysis due to bilateral occipital infarcts.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...